Ovid Therapeutics, Inc. (OVID)
2.20
-0.14
(-5.98%)
USD |
NASDAQ |
Nov 20, 16:00
2.205
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Price : 2.20 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | 2.26 | 2.325 | 2.17 | 2.20 | 2.834M |
| Nov 19, 2026 | 2.25 | 2.38 | 2.19 | 2.34 | 1.766M |
| Nov 18, 2026 | 2.19 | 2.32 | 2.17 | 2.26 | 2.155M |
| Nov 17, 2026 | 2.36 | 2.392 | 2.16 | 2.22 | 2.432M |
| Nov 16, 2026 | 2.52 | 2.655 | 2.37 | 2.40 | 2.797M |
| Nov 13, 2026 | 2.50 | 2.555 | 2.33 | 2.54 | 2.902M |
| Nov 12, 2026 | 2.77 | 2.77 | 2.51 | 2.55 | 2.925M |
| Nov 11, 2026 | 2.80 | 2.86 | 2.66 | 2.78 | 1.823M |
| Nov 10, 2026 | 2.76 | 2.87 | 2.64 | 2.80 | 2.308M |
| Nov 09, 2026 | 2.89 | 3.09 | 2.83 | 2.85 | 6.225M |
| Nov 06, 2026 | 2.56 | 2.945 | 2.558 | 2.85 | 3.898M |
| Nov 05, 2026 | 2.74 | 2.750 | 2.485 | 2.58 | 2.016M |
| Nov 04, 2026 | 2.50 | 2.79 | 2.375 | 2.74 | 3.610M |
| Nov 03, 2026 | 2.39 | 2.495 | 2.38 | 2.40 | 1.375M |
| Nov 02, 2026 | 2.55 | 2.60 | 2.37 | 2.39 | 2.337M |
| Oct 30, 2026 | 2.51 | 2.70 | 2.44 | 2.54 | 3.146M |
| Oct 29, 2026 | 2.45 | 2.58 | 2.405 | 2.56 | 2.044M |
| Oct 28, 2026 | 2.26 | 2.495 | 2.205 | 2.45 | 2.058M |
| Oct 27, 2026 | 2.18 | 2.28 | 2.10 | 2.26 | 1.692M |
| Oct 26, 2026 | 2.19 | 2.22 | 2.121 | 2.155 | 844073.0 |
| Oct 23, 2026 | 2.31 | 2.32 | 2.12 | 2.16 | 2.017M |
| Oct 22, 2026 | 2.45 | 2.50 | 2.34 | 2.37 | 1.178M |
| Oct 21, 2026 | 2.37 | 2.65 | 2.345 | 2.47 | 5.006M |
| Oct 20, 2026 | 2.19 | 2.46 | 2.175 | 2.36 | 3.669M |
| Oct 19, 2026 | 2.18 | 2.225 | 2.14 | 2.17 | 1.641M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 17.11 |
| Alnylam Pharmaceuticals, Inc. | 143.82 |
| Anika Therapeutics, Inc. | 13.23 |
| Savara, Inc. | 4.26 |
| Arrowhead Pharmaceuticals, Inc. | 41.37 |
Price Related Metrics
| PS Ratio | 234.37 |
| Price to Book Value | 2.090 |
| Earnings Yield | -8.40% |
| Market Cap | 415.19M |